TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Recipharm AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
603,602
|
705,541
|
595,436 |
| Financial expenses |
1,032,640
|
6,529,997
|
3,428,349 |
| Earnings before taxes |
5,316,812
|
-8,810,099
|
-21,087 |
| EBITDA |
-284,688
|
-306,495
|
-176,402 |
| Total assets |
20,283,987
|
22,947,164
|
29,509,387 |
| Current assets |
7,786,411
|
13,017,009
|
3,974,858 |
| Current liabilities |
2,453,913
|
4,399,448
|
2,114,465 |
| Equity capital |
7,831,597
|
9,163,215
|
17,984,299 |
| - share capital |
50,558
|
50,558
|
50,558 |
| Employees (average) |
44
|
60
|
67 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
38.6%
|
39.9%
|
60.9% |
| Turnover per employee |
13,718
|
11,759
|
8,887 |
| Profit as a percentage of turnover |
880.8%
|
-1248.7%
|
-3.5% |
| Return on assets (ROA) |
31.3%
|
-9.9%
|
11.5% |
| Current ratio |
317.3%
|
295.9%
|
188.0% |
| Return on equity (ROE) |
67.9%
|
-96.1%
|
-0.1% |
| Change turnover |
-101,939
|
110,105
|
347,562 |
| Change turnover % |
-14%
|
18%
|
140% |
| Chg. No. of employees |
-16
|
-7
|
3 |
| Chg. No. of employees % |
-27%
|
-10%
|
5% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.